For health care professionals

Provider education

Seattle Cancer Care Alliance (SCCA) provides symposiums, webinars and other educational programs about specific disease programs focusing on advancements to diagnostic techniques and treatment modalities. Our programs feature physician speakers from SCCA, Fred Hutch, UW Medicine and Seattle Children’s. 

Our mission

We strive to support SCCA’s mission of advancing the standard of oncology care throughout the region by providing high quality medical education to healthcare providers. Our oncology-specific education services focus on current and emerging standards of care and treatment options along the cancer care continuum with the goal of improving patient outcomes.

Practical clinical training

In addition to symposiums and webinars, SCCA offers other clinical education including multi-day training courses and shadowing programs.

Upcoming events

SCCA offers educational symposiums throughout the year, with focuses on research advancements to diagnostic techniques and treatment modalities.

13th Annual Comprehensive Hematology and Oncology Review Course
13th Annual Comprehensive Hematology and Oncology Review Course

This educational program will cover data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders. 

Immune-Related Adverse Events (irAEs) – A Series of Panels Exploring the Side Effects of Immunotherapy

Provider-focused discussions on immunotherapy-related treatment, research updates and clinical challenges. 

Panel 6 Topic: Dermatologic irAEs
Date: September 23, 2022
Guest Speaker: Mario E. Lacouture, MD, Professor and Director, Oncodermatology Program, Dermatology Service, Department of Medicine at Memorial Sloan-Kettering Cancer Center

The 90-minute sessions are approximately half didactic information presented by experts in the field and half panel case discussion and questions. Series co-chaired by Shailender Bhatia, MD and Petros Grivas, MD, PhD

Accreditation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Washington School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit.)

Non-monetary compensation: Free CME credit is offered with this live talk and if learners claim the free CME credit, the value is considered non-monetary compensation and tracked at $25 per learner, which meets Fair Market Value. Any learner can attend for free and choose not to claim free CME credit.

irAEs panel series presentations

Panel 1 Topic: Immune-Related GI Toxicity: updates and clinical dilemma
Recorded on April 24, 2021. Guest speaker is Yinghong (Mimi) Wang, MD, PhD, Associate Professor at MD Anderson Cancer Center.
Panel 2 Topic: Immune-Mediated Pneumonitis
Recorded on June 26, 2021. Guest speaker is Jarushka Naidoo, M.B.B.Ch, Assistant Professor of Oncology at Johns Hopkins.
Panel 3 Topic: Rheumatologic irAEs
Recorded on October 9, 2021. Guest speaker is Maria Suarez-Almazor, MD, PhD, Barnts Family Distinguished Professor at MD Anderson Cancer Center.
Panel 4 Topic: Renal irAEs: Nephrotoxicity of Immune Checkpoint Inhibitors
Recorded on January 29, 2022. Guest speaker is Shruti Gupta, MD, MPH, Director of Onco-Nephrology, Division of Renal Medicine, Brigham and Women’s Hospital/Dana-Farber Cancer Institute.
Panel 5 Topic: ICI-induced Myocarditis
Recorded April 8, 2022. Guest Speaker is Tomas Neilan, MD, MPH Director, Cardio-Oncology Program and Co-Director, Cardiac MR PET CT Program at Massachusetts General Hospital.

Archived presentations 2017-2018

The following webinars are no longer available for CME credit.

Caring for patients after hematopoietic cell transplantation
Selection of therapy for untreated patients with diffuse large B cell lymphoma and follicular lymphoma
CD19 CAR T-cell immunotherapy for B cell malignancies
Getting your patients to and through allotransplant
Contemporary management of the small renal mass
The role of proton beam radiotherapy in solid tumors
The HPV + head and neck cancer epidemic
Risk based breast cancer screening
Thyroid cancer: incidence, diagnosis and treatment
Innovations and updates in the surgical treatment of colorectal cancer
New discoveries in prostate cancer genetics
Lung cancer screening